OncoImmunity
NEC OncoImmunity AS is a bioinformatics company offering proprietary machine learning-based software called the NEC Immune Profiler, which addresses the key knowledge gaps in the prediction of bona fide immunogenic neoantigens for personalized cancer immunotherapy. The NEC Immune Profiler can be used to identify optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable timeframe, and also facilitate effective patient selection for cancer immunotherapy.
Last updated on
About OncoImmunity
Founded
2014Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$7MCategory
Industry
BiotechnologyLocation
City
OsloState
OsloCountry
NorwayOncoImmunity
Find your buyer within OncoImmunity